Brief: Neurizon Therapeutics Raises A$5 Million At A$0.12 Per Share
18/09/2025 01:04
Sept 18 (Reuters) - Neurizon Therapeutics Ltd NUZ.AX: RAISES A$5 MILLION VIA INSTITUTIONAL PLACEMENT AT A$0.12 PER SHARE Further company coverage: NUZ.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon Therapeutics jumps on deal with US firm
Brief: Neurizon Therapeutics Executes Long-Term Supply Agreement With Elanco
Brief: Neurizon Therapeutics Receives Ethics Approval For Phase 1 Nuz-001 Oral Liquid Formulation Study
Brief: Neurizon Therapeutics Announces Placement Of Entitlement Offer Shortfall To Raise ~A$2.7 Million
Brief: Neurizon Therapeutics Says Michael Thurn Resigns As Managing Director And CEO